These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 19679704

  • 1. Uptake of treatment for osteoporosis and compliance after bone density measurement in the community.
    Dugard MN, Jones TJ, Davie MW.
    J Epidemiol Community Health; 2010 Jun; 64(6):518-22. PubMed ID: 19679704
    [Abstract] [Full Text] [Related]

  • 2. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [Abstract] [Full Text] [Related]

  • 3. Persistence to medical treatment of osteoporosis in women at three different clinical settings--a historical cohort study.
    Nielsen DS, Langdahl BL, Sørensen OH, Sørensen HA, Brixen KT.
    Scand J Public Health; 2010 Jul; 38(5):502-7. PubMed ID: 20484306
    [Abstract] [Full Text] [Related]

  • 4. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].
    Nishida A, Ito M.
    Clin Calcium; 2011 Jan; 21(1):120-3. PubMed ID: 21187605
    [Abstract] [Full Text] [Related]

  • 5. Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
    Emkey RD, Ettinger M.
    Am J Med; 2006 Apr; 119(4 Suppl 1):S18-24. PubMed ID: 16563937
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.
    McHorney CA, Schousboe JT, Cline RR, Weiss TW.
    Curr Med Res Opin; 2007 Dec; 23(12):3137-52. PubMed ID: 17988435
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem.
    Cramer JA, Silverman S.
    Am J Med; 2006 Apr; 119(4 Suppl 1):S12-7. PubMed ID: 16563936
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.
    Gold DT, Alexander IM, Ettinger MP.
    Ann Pharmacother; 2006 Jun; 40(6):1143-50. PubMed ID: 16735667
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J, Vanuga P, Payer J, Svobodník A.
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [Abstract] [Full Text] [Related]

  • 15. Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents.
    Gupta G, Aronow WS.
    J Am Med Dir Assoc; 2003 Mar; 4(4):200-2. PubMed ID: 12837141
    [Abstract] [Full Text] [Related]

  • 16. Influence of bone densitometry results on the treatment of osteoporosis.
    Fitt NS, Mitchell SL, Cranney A, Gulenchyn K, Huang M, Tugwell P.
    CMAJ; 2001 Mar 20; 164(6):777-81. PubMed ID: 11276543
    [Abstract] [Full Text] [Related]

  • 17. Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: a retrospective case-control analysis.
    Cotté FE, Mercier F, De Pouvourville G.
    Clin Ther; 2008 Dec 20; 30(12):2410-22. PubMed ID: 19167600
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.